Liu F, Iqbal K, Grundke-Iqbal I, Hart GW, Gong CX.
O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.
Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10804-9.
Please login to recommend the paper.
To make a comment you must login or register.
In their recent article, Liu et al provided clear evidence that abnormal hyperphospharylation of tau protein may be induced by decreased 0-GlcNAcylation subsequent to a deficient glucose metabolism in Alzheimer disease (AD) brain. Experimentally, the authors damaged brain glucose metabolism by starvation for 48 hours, and this decreased 0-GlcNAcylation resulting in tau-protein hyperphosphorylation. Based on these results, the authors assumed that sporadic AD might be a metabolic brain disorder caused by abnormal cerebral glucose metabolism.
Some supplemental arguments may support this review.
During their processing from the immature to the mature state, proteins undergo modifications including 0-glycosylation and 0-GlcNAcylation. This process takes place in the endoplasmic reticulum (ER)/Golgi apparatus (GA) (1). The function of these intracellular compartments is ensured at a pH of 6 (2), the maintenance of which is ATP-dependent (3).
In sporadic AD brain, ATP formation has been found to be reduced in parallel to the severity of dementia (4) subsequent to decreased glucose comsumption and pertubed glucose metabolism of the brain (5,6). This pathologic condition may reduce neuronal activity, which may diminish the size of the GA (7,8). As a consequence, the processing of proteins in ER/GA may become abnormal, resulting in e.g., hyperphosphorylated tau-protein.
Interestingly, arterial hypoglycemia (as present in starvation) caused an imbalance between normal cerebral oxygen consumption and reduced cerebral glucose utilization (9;10), and this was demonstrated for AD brain, too (5).
Nosologically, AD is not one single disorder. Early-onset autosomal dominant familial AD has been documented in 326 families worldwide (11). The amyloid cascade hypothesis serves as the scientific basis of inherited AD. In contrast, millions of people suffer from sporadic AD worldwide, the main risk factor of which is aging. There is no evidence that the amyloid cascade hypothesis is valid for sporadic AD. Instead, there is evidence that a disturbance in the neuronal insulin signal transduction pathway controlling cerebral glucose metabolism may be a central and early pathophysiologic event in sporadic AD (12,13). On the basis of patients‘ data and results from animal studies, the hypothesis was advanced that sporadic AD is the diabetes mellitus II of the brain, and this would include the non-genetic formation of amyloidogenic derivatives and hyperphosphorylated tau-protein. Thus, the findings of Liu et al fit with our hypothesis and support the view that sporadic AD is an age-related metabolic brain disorder (15).
References:1. Hirschberg CB, Snider MD. Topography of glycosylation in the rough endoplasmic reticulum and Golgi apparatus. Annu Rev Biochem. 1987;56:63-87. Review. No abstract available. Abstract
2. Seksek O, Biwersi J, Verkman AS. Direct measurement of trans-Golgi pH in living cells and regulation by second messengers. J Biol Chem. 1995 Mar 10;270(10):4967-70. Abstract
3. Verde C, Pascale MC, Martire G, Lotti LV, Torrisi MR, Helenius A, Bonatti S. Effect of ATP depletion and DTT on the transport of membrane proteins from the endoplasmic reticulum and the intermediate compartment to the Golgi complex. Eur J Cell Biol. 1995 Jul;67(3):267-74. Abstract
4. Hoyer S. Oxidative energy metabolism in Alzheimer brain. Studies in early-onset and late-onset cases.
Mol Chem Neuropathol. 1992 Jun;16(3):207-24. Abstract
5. Hoyer S, Nitsch R, Oesterreich K. Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: a cross-sectional comparison against advanced late-onset and incipient early-onset cases. J Neural Transm Park Dis Dement Sect. 1991;3(1):1-14. Abstract
6. Hoyer S. xidative metabolism deficiencies in brains of patients with Alzheimer's disease.
Acta Neurol Scand Suppl. 1996;165:18-24. Review. Abstract
7. Salehi A, Lucassen PJ, Pool CW, Gonatas NK, Ravid R, Swaab DF. Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatus.
Neuroscience. 1994 Apr;59(4):871-80. Abstract
8. Swaab DF, Lucassen PJ, Salehi A, Scherder EJ, van Someren EJ, Verwer RW. Reduced neuronal activity and reactivation in Alzheimer's disease. Prog Brain Res. 1998;117:343-77. Review. Abstract
9. Eisenberg S, Seltzer HS (1962) Metabolism 11: 1162-1168.
10. Gottstein U, Held K (1967) Klin Wschr 43: 965-976.
11. http://molgen-www.uia.ac.be/AD Mutations
12. Hoyer S. The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update.
J Neural Transm. 2002 Mar;109(3):341-60. Review. Abstract
13. Hoyer S. Glucose metabolism and insulin receptor signal transduction in Alzheimer disease.
Eur J Pharmacol. 2004 Apr 19;490(1-3):115-25. Abstract
14. Hoyer S. Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. J Neural Transm. 1998;105(4-5):415-22. Abstract
15. Holness MJ, Langdown ML, Sugden MC. Early-life programming of susceptibility to dysregulation of glucose metabolism and the development of Type 2 diabetes mellitus. Biochem J. 2000 Aug 1;349 Pt 3:657-65. Review. Abstract